Previous close | 5.70 |
Open | 5.85 |
Bid | 6.43 x 0 |
Ask | 6.43 x 0 |
Day's range | 5.45 - 6.44 |
52-week range | 3.84 - 15.50 |
Volume | |
Avg. volume | 591,803 |
Market cap | 351.234M |
Beta (5Y monthly) | 2.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | -79.20 |
Earnings date | 12 Jun 2024 - 17 Jun 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.83 |
In this article, we discuss 10 cannabis ETFs to explore. If you want to skip our detailed discussion on the cannabis industry, head directly to Navigating Regulatory Changes: 5 Cannabis ETFs To Explore. In September last year, shares of marijuana firms fell after rising initially, following a US Senate Committee’s vote to pass a bill […]
Cannabis-related stocks such as Tilray Brands (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB) jumped on news out of Canada and Germany. In Canada, a government group brought together to study the impacts of the legalization legislation recommends the country reduce the excise taxes producers have to pay. Meanwhile, Germany has decriminalized cannabis for personal use. Yahoo Finance's Josh Lipton and Julie Hyman discuss the moves in the video above. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Stephanie Mikulich.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) – The Canadian based leading global medical cannabis company has received Good Manufacturing Practice (GMP) certification from Australia's Therapeutic Goods Administration (TGA) for its Canadian production facilities, River and Ridge. The TGA is responsible for regulating the supply, import, export, manufacturing and advertising of therapeutic goods in Australia. Obtaining TGA's GMP certification enables the company to deliver top-tier cannabis produ